The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-4-((8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-N-(3-hydroxypropyl)benzenesulfonamide ID: ALA4169129
PubChem CID: 141451364
Max Phase: Preclinical
Molecular Formula: C23H32N6O4S
Molecular Weight: 488.61
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)NCCCO)cc3)nc2N1C1CCCC1
Standard InChI: InChI=1S/C23H32N6O4S/c1-3-19-22(31)28(2)20-15-24-23(27-21(20)29(19)17-7-4-5-8-17)26-16-9-11-18(12-10-16)34(32,33)25-13-6-14-30/h9-12,15,17,19,25,30H,3-8,13-14H2,1-2H3,(H,24,26,27)/t19-/m1/s1
Standard InChI Key: GSXMJWLLQORXFR-LJQANCHMSA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
4.1355 -12.5922 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5482 -13.3062 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.9607 -12.5897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2608 -13.7147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2597 -14.5384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9718 -14.9515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6856 -14.5379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6828 -13.7111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9700 -13.3059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8371 -13.7151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3981 -14.9495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1052 -14.5357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8143 -14.9478 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8067 -13.3051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0989 -13.7165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5242 -13.7124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5212 -14.5317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2259 -14.9437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9381 -14.5368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9411 -13.7175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2319 -13.3051 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2337 -12.4838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6548 -13.3122 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6479 -14.9531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6438 -15.7744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2264 -15.7619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5629 -16.2389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8116 -17.0174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6288 -17.0215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8851 -16.2455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8357 -14.5323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1273 -14.9396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1259 -15.7568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4175 -16.1642 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 2 1 0
2 10 1 0
7 11 1 0
11 12 1 0
12 13 2 0
13 17 1 0
16 14 1 0
14 15 2 0
15 12 1 0
16 17 2 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
20 23 2 0
19 24 1 1
24 25 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 26 1 0
18 26 1 0
10 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 488.61Molecular Weight (Monoisotopic): 488.2206AlogP: 2.38#Rotatable Bonds: 9Polar Surface Area: 127.76Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.63CX Basic pKa: 4.00CX LogP: 2.32CX LogD: 2.32Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.46Np Likeness Score: -1.10
References 1. Zhan MM, Yang Y, Luo J, Zhang XX, Xiao X, Li S, Cheng K, Xie Z, Tu Z, Liao C.. (2018) Design, synthesis, and biological evaluation of novel highly selective polo-like kinase 2 inhibitors based on the tetrahydropteridin chemical scaffold., 143 [PMID:29220793 ] [10.1016/j.ejmech.2017.11.058 ]